John V. Bennett

6.3k total citations · 2 hit papers
83 papers, 5.0k citations indexed

About

John V. Bennett is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, John V. Bennett has authored 83 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 24 papers in Infectious Diseases and 19 papers in Health. Recurrent topics in John V. Bennett's work include Virology and Viral Diseases (23 papers), Vaccine Coverage and Hesitancy (19 papers) and Respiratory viral infections research (15 papers). John V. Bennett is often cited by papers focused on Virology and Viral Diseases (23 papers), Vaccine Coverage and Hesitancy (19 papers) and Respiratory viral infections research (15 papers). John V. Bennett collaborates with scholars based in United States, Mexico and United Kingdom. John V. Bennett's co-authors include Jean L. Brodie, E. Jack Benner, William Kirby, Bernard R. Aserkoff, Dennis G. Maki, Felicity T. Cutts, Frank S. Rhame, Robert W. Haley, J Fernández de Castro and Howard E. Freeman and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Annals of Internal Medicine.

In The Last Decade

John V. Bennett

83 papers receiving 4.2k citations

Hit Papers

Simplified, Accurate Meth... 1966 2026 1986 2006 1966 1966 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
John V. Bennett 1.7k 1.1k 1.1k 777 678 83 5.0k
Melvin I. Marks 1.8k 1.0× 1.1k 1.0× 628 0.6× 204 0.3× 552 0.8× 194 4.2k
Theodore C. Eickhoff 1.4k 0.8× 739 0.6× 343 0.3× 294 0.4× 365 0.5× 98 3.2k
Calvin M. Kunin 2.8k 1.7× 934 0.8× 1.1k 1.1× 352 0.5× 706 1.0× 173 6.8k
Urs B. Schaad 1.7k 1.0× 791 0.7× 744 0.7× 152 0.2× 361 0.5× 94 3.5k
Ethan Rubinstein 2.4k 1.4× 2.4k 2.1× 1.8k 1.7× 357 0.5× 1.8k 2.6× 140 6.8k
Margareta Ieven 3.6k 2.1× 2.0k 1.7× 292 0.3× 308 0.4× 490 0.7× 159 6.6k
Michael M. McNeil 3.3k 1.9× 2.9k 2.6× 446 0.4× 527 0.7× 148 0.2× 178 7.4k
Robert R. Muder 2.7k 1.6× 2.5k 2.2× 487 0.5× 1.3k 1.6× 870 1.3× 120 6.8k
Mathias W. Pletz 3.2k 1.9× 1.9k 1.7× 631 0.6× 401 0.5× 1.1k 1.7× 400 7.8k
Wang‐Huei Sheng 2.9k 1.7× 2.7k 2.4× 648 0.6× 665 0.9× 1.5k 2.2× 294 6.9k

Countries citing papers authored by John V. Bennett

Since Specialization
Citations

This map shows the geographic impact of John V. Bennett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John V. Bennett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John V. Bennett more than expected).

Fields of papers citing papers by John V. Bennett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John V. Bennett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John V. Bennett. The network helps show where John V. Bennett may publish in the future.

Co-authorship network of co-authors of John V. Bennett

This figure shows the co-authorship network connecting the top 25 collaborators of John V. Bennett. A scholar is included among the top collaborators of John V. Bennett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John V. Bennett. John V. Bennett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Díaz‐Ortega, José Luis, et al.. (2014). Booster immune response in children 6–7 years of age, randomly assigned to four groups with two MMR vaccines applied by aerosol or by injection. Vaccine. 32(29). 3680–3686. 16 indexed citations
2.
Díaz‐Ortega, José Luis, et al.. (2012). Aerosolized MMR vaccine: Evaluating potential transmission of components to vaccine administrators and contacts of vaccinees. Biologicals. 40(4). 278–281. 4 indexed citations
3.
Bennett, John V., et al.. (2009). A new, rapid, and promising approach to aerosol immunization: Inflatable bags and valved masks. Vaccine. 27(34). 4571–4575. 9 indexed citations
4.
Dilraj, Athmanundh, et al.. (2007). Aerosol and subcutaneous measles vaccine: Measles antibody responses 6 years after re-vaccination. Vaccine. 25(21). 4170–4174. 46 indexed citations
5.
Valdespino‐Gómez, José Luis, et al.. (2006). Measles Aerosol Vaccination. Current topics in microbiology and immunology. 304. 165–193. 19 indexed citations
6.
Zieliński, Andrzej, et al.. (2003). Risk of Haemophilus influenzae type b meningitis in Polish children varies directly with number of siblings: Possible implications for vaccination strategies. European Journal of Epidemiology. 18(9). 917–922. 12 indexed citations
7.
Sepúlveda-Amor, Jaime, José Luis Valdespino‐Gómez, Lourdes García‐García, et al.. (2002). A randomized trial demonstrating successful boosting responses following simultaneous aerosols of measles and rubella (MR) vaccines in school age children. Vaccine. 20(21-22). 2790–2795. 46 indexed citations
8.
Dilraj, Athmanundh, Felicity T. Cutts, John V. Bennett, et al.. (2000). PERSISTENCE OF MEASLES ANTIBODY TWO YEARS AFTER REVACCINATION BY AEROSOL OR SUBCUTANEOUS ROUTES. The Pediatric Infectious Disease Journal. 19(12). 1211–1213. 32 indexed citations
9.
Bennett, John V.. (1999). Seroconversions in unvaccinated infants: further evidence for subclinical measles from vaccine trials in Niakhar, Senegal. International Journal of Epidemiology. 28(1). 147–151. 17 indexed citations
10.
Whittle, Hilton, et al.. (1999). Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa. The Lancet. 353(9147). 98–102. 143 indexed citations
11.
Bennett, John V., et al.. (1999). Circumcision and neonatal tetanus: disclosure of risk and its reduction by topical antibiotics. International Journal of Epidemiology. 28(2). 263–266. 17 indexed citations
12.
Bennett, John V., et al.. (1999). Dry powder inhalation as a potential delivery method for vaccines. Vaccine. 17(13-14). 1796–1803. 71 indexed citations
13.
Bennett, John V., et al.. (1999). Edmonston-Zagreb Measles Vaccine: A Good Vaccine With an Image Problem. PEDIATRICS. 104(5). 1123–1123. 10 indexed citations
14.
Seng, Rémonie, Badara Samb, François Simondon, et al.. (1999). Increased long term mortality associated with rash after early measles vaccination in rural Senegal. The Pediatric Infectious Disease Journal. 18(1). 48–52. 9 indexed citations
15.
Migasena, S, Sriluck Simasathien, P Pitisuttitham, et al.. (1998). Adverse impact of infections on antibody responses to measles vaccination. Vaccine. 16(6). 647–652. 10 indexed citations
16.
Rhame, Frank S., Dennis G. Maki, John V. Bennett, & William R. Jarvis. (1997). Epidemiologic notes and reports nosocomial bacteremias associated with intravenous fluid therapy - USA. MMWR Morbidity and Mortality Weekly Report. 46(51). 1227–1233. 6 indexed citations
17.
Simasathien, Sriluck, S Migasena, William J. Bellini, et al.. (1997). Measles vaccination of Thai infants by intranasal and subcutaneous routes: possible interference from respiratory infections. Vaccine. 15(3). 329–334. 8 indexed citations
18.
Bennett, John V., et al.. (1997). Protective effects of topical antimicrobials against neonatal tetanus. International Journal of Epidemiology. 26(4). 897–903. 31 indexed citations
19.
Samb, Badara, Peter Aaby, Awa Seck, et al.. (1995). Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal. The Pediatric Infectious Disease Journal. 14(3). 203–208. 119 indexed citations
20.
Bennett, John V.. (1991). Child Survival and Perinatal Infections With Human Immunodeficiency Virus. Archives of Pediatrics and Adolescent Medicine. 145(11). 1242–1242. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026